6645 Jinwanlin Innovation: Announcement of Commitments Made at Initial Innovation Board Listing Application and Subsequent Implementation Status

Release Date: July 10, 2026 Statement Date: July 9, 2026 Statement Time: 15:37:25 Company Code: 6645 Company Name: Jinwanlin Innovation Subject: Announcement of Commitments Made by the Company at Initial Application for Innovation Board Listing and Subsequent Implementation Status Applicable Clause: Clause 51 Event Date: July 9, 2026

Details: 1. Event Date: July 9, 2026 2. Company Name: Jinwanlin Enterprise Co., Ltd. 3. Relationship with Company (Please enter '本公司' or 'Subsidiary'):本公司 (Our Company) 4. Cross-shareholding Ratio: Not applicable 5. Reason for Announcement: In accordance with the letter issued by the Taiwan Stock Exchange Corporation on September 28, 2023 (No. 1121703609), this announcement discloses the implementation status of commitments made by the Company at the time of its initial application for listing on the Innovation Board, as of the second quarter of 2026.

At the time of its initial application for listing on the Innovation Board, the Company submitted the following commitments as required by the Taiwan Stock Exchange Corporation:

1. Disclosure in the 'Special Notes' section of the prospectus: (1) The Company continues to develop genetic and metabolomic testing and analysis services. Please explain the key core technologies, competitive landscape, future development strategies, and risk mitigation measures. (2) The Company has significantly increased revenue from pandemic-related reagents and testing services over the past two years, achieving profitability. However, as the pandemic subsides, please explain how the Company will sustain its operational momentum. (3) Explain the rationale, necessity, operational risks, and mitigation measures regarding the concentration of procurement from the top two suppliers.

2. For directors, managers, and core technical personnel who are also employees and have been granted employee stock options prior to the listing commencement date, any ordinary shares converted upon exercise of such rights shall be submitted to centralized custody in accordance with Article 35 of the Rules Governing the Listing and Trading of Securities on the Taiwan Stock Exchange.

3. The cover page of the prospectus shall clearly state in prominent font: "This company applies for listing on the Innovation Board under Article 29, Paragraph 1 of the Listing Rules and is not subject to traditional profitability requirements. The business involves significant risks and is restricted to qualified investors only. Investors should exercise particular caution." Additionally: "The Company commits to continue engaging its lead underwriter to assist in compliance with the securities laws and regulations of the Republic of China, the rules of the Taiwan Stock Exchange, public announcements, and the listing agreement for the listing year and the following three fiscal years. If the engagement with the lead underwriter is terminated during the listing period, the Company shall appoint another securities underwriter as successor within one month from the effective date of termination."

4. The Company commits that for the three fiscal years following the year after listing, when submitting the annual report, it will simultaneously disclose and file with the designated internet information reporting system, and in written form, the accountant's special review report for the previous fiscal year.

6. Countermeasures Taken: (1) The disclosures have been included in the 'Special Notes' section of the prospectus used for the initial public offering and first listing. (2) On September 3, 2024, certain directors, managers, and core technical personnel who are also employees exercised their stock options, and the converted shares have been delivered to mandatory centralized custody. (3) The required statements have been printed on the cover of the prospectus prior to listing. Furthermore, the Company has signed a Securities Regulatory Compliance Guidance Agreement with the lead underwriter as per the commitment. (4) The Company has submitted and disclosed the accountant's special review report for the 2025 fiscal year as committed.

7. Other Matters to be Disclosed: (If the event or resolution involves a publicly issued company or above, this material information also qualifies as a matter under Article 7, Paragraph 9 of the Enforcement Rules of the Securities and Exchange Act that significantly affects shareholders' rights or securities prices): None